Marshall Wace
GH icon

Marshall Wace’s Guardant Health GH Stock Holding History

Marshall Wace’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-171,206
Closed -$17.5M – 3389
2025
Q4 		$17.5M Sell
171,206
-70,100
-29% -$6.27M 0.02% 672
2025
Q3 		$15.1M Buy
+241,306
New +$13.1M 0.02% 769
2025
Q2 		– Sell
-176,533
Closed -$7.52M – 2878
2025
Q1 		$7.52M Buy
176,533
+144,448
+450% +$6.23M 0.01% 882
2024
Q4 		$980K Buy
+32,085
New +$903K ﹤0.01% 1747
2024
Q2 		– Sell
-119,878
Closed -$2.47M – 2690
2024
Q1 		$2.47M Buy
+119,878
New +$2.57M ﹤0.01% 1263
2023
Q3 		– Sell
-353,333
Closed -$12.6M – 2375
2023
Q2 		$12.6M Buy
353,333
+332,733
+1,615% +$9.56M 0.02% 635
2023
Q1 		$483K Buy
20,600
+12,606
+158% +$360K ﹤0.01% 2114
2022
Q4 		$217K Buy
+7,994
New +$366K ﹤0.01% 2677
2022
Q1 		– Sell
-3,954
Closed -$396K – 3573
2021
Q4 		$396K Buy
+3,954
New +$409K ﹤0.01% 2915
2021
Q3 		– Sell
-336,204
Closed -$41.8M – 3168
2021
Q2 		$41.8M Buy
336,204
+288,913
+611% +$38.9M 0.19% 94
2021
Q1 		$7.22M Sell
47,291
-899,591
-95% -$136M 0.03% 629
2020
Q4 		$122M Buy
946,882
+15,300
+2% +$1.76M 0.66% 25
2020
Q3 		$104M Sell
931,582
-586,500
-39% -$53.7M 0.67% 22
2020
Q2 		$123M Buy
1,518,082
+833,174
+122% +$67.1M 0.86% 19
2020
Q1 		$47.7M Buy
+684,908
New +$52.6M 0.48% 41

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace's GH Position: Q1 2026 in Review

Marshall Wace sold out of Guardant Health (GH) in Q1 2026, closing a stake of 171,206 shares — an estimated $17.5M sold.

Marshall Wace first reported a position in GH in Q1 2020 and held it in 15 quarters. The position peaked at $123M in Q2 2020. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Marshall Wace reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Marshall Wace sold 171,206 Guardant Health shares in Q1 2026, an estimated $17.5M.
  • Marshall Wace first reported a position in Guardant Health in Q1 2020 and held it in 15 quarters.
  • Marshall Wace's Guardant Health position peaked at $123M in Q2 2020.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.